Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Pacific Edge Limited ( (PFGTF) ) has provided an announcement.
Pacific Edge Limited announced the cessation of 1,928,988 securities due to the expiry of options or other convertible securities without exercise or conversion. This development may impact the company’s capital structure and could have implications for its financial strategies and investor relations.
More about Pacific Edge Limited
Pacific Edge Limited operates in the biotechnology industry, focusing on developing and commercializing diagnostic tests for the early detection and management of cancer. The company is known for its innovative solutions aimed at improving patient outcomes and has a market focus on healthcare providers and patients globally.
For detailed information about PFGTF stock, go to TipRanks’ Stock Analysis page.